Management of Hypertension in Solid-Organ Transplantation
2005 ◽
Vol 15
(1)
◽
pp. 17-22
◽
Keyword(s):
Posttransplant hypertension is a major risk factor for cardiovascular disease and chronic renal allograft dysfunction. A significant number of transplant recipients suffer from posttransplant hypertension in part because of corticosteroid and calcineurin inhibitor use. Although the optimal blood pressure range and the antihypertensive agents of choice in the transplant population have not been determined, the guidelines for blood pressure control in the general population can be extrapolated to the transplant population. The choice of an antihypertensive regimen should be tailored on the basis of the individual patient's risk factors and comorbidities.
Keyword(s):
2020 ◽
Vol 26
(28)
◽
pp. 3497-3506
2021 ◽
Vol 39
(15_suppl)
◽
pp. e19046-e19046
2005 ◽
Vol 6
(1_suppl)
◽
pp. S8-S11
2010 ◽
Vol 29
(2)
◽
pp. S159-S159
2009 ◽
Vol 41
(10)
◽
pp. 4184-4187
◽
The first Russian national multicenter study - ROBLS (Russian Optimal Blood pressure Lowering Study)
2003 ◽
Vol 9
(5)
◽
pp. 151-154